Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indocyanine Green PDT for Periodontitis
NCT03557827Phase 3Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Mar 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of indocyanine green in periodontitis (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Change in gingival bleeding index at 6 months. Status: unknown.
02
Drugs
indocyanine green
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT03557827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03557827.